Outstanding treatment for aesthetic indications and fat disorders About Raziel Therapeutics Raziel Therapeutics is a clinical-stage pharmaceutical company developing RZL-012, an injectable treatment for aesthetics and a variety of fat disorders. A single treatment session in which RZL-012 is injected into subcutaneous fat, results in significant and sustained reduction in fat volume. Read More About…
Location: Israel, Center District, Rehovot
Total raised: $22M
Investors 2
| Date | Name | Website |
| - | Quark Vent... | quarkventu... |
| - | Pontifax V... | pontifax.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.12.2019 | Series C | $22M | - |
Mentions in press and media 1
| Date | Title | Description | Source |
| 19.12.2019 | Raziel Therapeutics Raises $22M in Series C Funding | Raziel Therapeutics, a Rehovot, Israel-based clinical-stage pharmaceutical company, raised $22m in S... | finsmes.co... |